NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children's
January 28, 2019
January 28, 2019
CINCINNATI, Ohio, Jan. 28 -- The Cincinnati Children's Hospital Medical Center issued the following news release:
* * *
- Study in Healthy Adults Tests Body's Immune Response
* * *
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Dis . . .
* * *
- Study in Healthy Adults Tests Body's Immune Response
* * *
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Dis . . .